Recent Quarter Total Invested
$229.55 M
Recent Quarter Institutional Ownership Percentage
94.05%
Total Invested of Last Quarter
$526.34 M
Ownership Percentage of Last Quarter
97.41%
Mersana Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 08/14/2024 | 19.36 M | $38.92 M | 0.00% | 15.95% |
| VR ADVISER, LLC | 08/14/2024 | 11.33 M | $22.77 M | 0.00% | 9.33% |
| NEXTECH INVEST LTD. | 08/14/2024 | 9.53 M | $19.15 M | 147.03% | 7.85% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/12/2024 | 8.66 M | $17.41 M | 0.00% | 7.14% |
| BLACKROCK INC. | 08/13/2024 | 8.38 M | $16.85 M | 3.56% | 6.90% |
| VANGUARD GROUP INC | 08/13/2024 | 6.70 M | $13.47 M | 6.82% | 5.52% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 3.05 M | $6.12 M | 0.00% | 2.51% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 2.98 M | $5.98 M | 195.14% | 2.45% |
| CITADEL ADVISORS LLC | 08/14/2024 | 2.74 M | $5.51 M | -20.68% | 2.26% |
| STATE STREET CORP | 08/14/2024 | 2.68 M | $5.39 M | -51.21% | 2.21% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 2.60 M | $5.23 M | 0.00% | 2.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 2.50 M | $5.03 M | -15.77% | 2.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 2.49 M | $5.01 M | 5.73% | 2.05% |
| MORGAN STANLEY | 08/14/2024 | 2.27 M | $4.57 M | -22.77% | 1.87% |
| JPMORGAN CHASE & CO | 08/12/2024 | 1.98 M | $3.97 M | 38.50% | 1.63% |
| ACUTA CAPITAL PARTNERS, LLC | 08/14/2024 | 1.66 M | $3.34 M | -23.17% | 1.37% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 1.58 M | $3.17 M | -0.58% | 1.30% |
| WOODLINE PARTNERS LP | 08/14/2024 | 1.47 M | $2.95 M | -50.00% | 1.21% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 1.47 M | $2.95 M | 19.87% | 1.21% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 1.45 M | $2.91 M | 1.43% | 1.19% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2024 | 1.31 M | $2.62 M | 0.00% | 1.07% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.24 M | $2.50 M | 85.09% | 1.03% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 1.09 M | $2.18 M | 0.00% | 0.89% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 992,565 | $2.00 M | 3.43% | 0.82% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 992,000 | $1.99 M | -0.80% | 0.82% |
| NORTHERN TRUST CORP | 08/14/2024 | 900,621 | $1.81 M | -4.71% | 0.74% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 767,000 | $1.54 M | -23.30% | 0.63% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 748,690 | $1.50 M | 243.52% | 0.62% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 719,300 | $1.45 M | 361.68% | 0.59% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 691,785 | $1.39 M | -54.11% | 0.57% |
| UBS OCONNOR LLC | 08/14/2024 | 544,293 | $1.09 M | 25.33% | 0.45% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 532,866 | $1.07 M | -0.33% | 0.44% |
| CLARIVEST ASSET MANAGEMENT LLC | 08/07/2024 | 500,498 | $1.01 M | 6.07% | 0.41% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 485,593 | $976,042 | -40.04% | 0.40% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 475,500 | $955,755 | 104.69% | 0.39% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 452,829 | $910,186 | 19.56% | 0.37% |
| BARCLAYS PLC | 08/14/2024 | 372,717 | $750,000 | -8.92% | 0.31% |
| ATOM INVESTORS LP | 08/14/2024 | 365,435 | $734,524 | -16.80% | 0.30% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2024 | 336,079 | $675,519 | 316.27% | 0.28% |
| JANE STREET GROUP, LLC | 08/15/2024 | 317,332 | $637,838 | -14.38% | 0.26% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 312,630 | $628,386 | 5.66% | 0.26% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 08/15/2024 | 308,691 | $620,469 | 31.85% | 0.25% |
| HRT FINANCIAL LP | 08/12/2024 | 259,689 | $521,000 | 100.00% | 0.21% |
| SQUAREPOINT OPS LLC | 08/14/2024 | 252,804 | $508,136 | 100.00% | 0.21% |
| FMR LLC | 08/13/2024 | 245,408 | $493,270 | -24.63% | 0.20% |
| PANAGORA ASSET MANAGEMENT INC | 07/29/2024 | 236,225 | $474,812 | 0.08% | 0.19% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 186,060 | $373,981 | 10.22% | 0.15% |
| FEDERATED HERMES, INC. | 08/08/2024 | 185,507 | $372,869 | 105,301.70% | 0.15% |
| HEALTHINVEST PARTNERS AB | 08/14/2024 | 184,900 | $371,649 | 84.90% | 0.15% |
| RHUMBLINE ADVISERS | 08/01/2024 | 176,063 | $353,876 | -1.61% | 0.15% |
Mersana Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of MRSN shares?
During the previous two years, 159 institutional investors and hedge funds held shares of Mersana Therapeutics, Inc.. The most heavily invested institutionals were:
EcoR1 Capital, LLC: 19.36 M
VR Adviser, LLC: 11.33 M
Nextech Invest Ltd.: 9.53 M
Bain Capital Life Sciences Investors, LLC: 8.66 M
BlackRock Inc.: 8.38 M
VANGUARD GROUP INC: 6.7 M
-
What percentage of Mersana Therapeutics, Inc. stock is owned by institutional investors?
94.05% of Mersana Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at MRSN ?
Institutional investors have bought a total of 120.50 M shares in the last 24 months. This purchase volume represents approximately $227.75 M in transactions.